Clinical Trial Update: Therapeutic Anticoagulation Strategy for Acute Chest Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating therapeutic anticoagulation strategy for Acute Chest Syndrome in sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chest Syndrome
• Sickle Cell Disease

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Anemia, Sickle Cell | Phase 3 | Status: COMPLETED